Publications by Dr Karim Bennaceur - ePrints

Browsing publications by Dr Karim Bennaceur.

Newcastle Authors	Title	Year
Dr Rachael Redgrave Dr Esha Singh Dr Simon Tual-Chalot Dr Catherine Park Dr Darroch Hall et al.	Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size	2024
Dr Bilal Bawamia Dr Luke Spray Vincent Wangsaputra Dr Karim Bennaceur Dr Sharareh Vahabi et al.	Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction Randomized Pilot Trial	2023
Dr Kateryna Sopova Dr Simon Tual-Chalot Dr Nikolaos Vlachogiannis Dr Georgios Georgiopoulos Dr Luke Spray et al.	Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction	2023
Professor Ioakim Spyridopoulos Dr Bilal Bawamia Dr Luke Spray Vincent Wangsaputra Professor Konstantinos Stellos et al.	Activation of mitochondrial telomerase reverses relative lymphopenia post myocardial infarction: results from the randomised, double-blinded TACTIC phase IIa pilot trial	2022
Dr Luke Spray Dr Catherine Park Dr Suzanne Cormack Dr Ashfaq Mohammed Dr Stephen Boag et al.	The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling	2021
Dr Catherine Park Dr Suzanne Cormack Dr Stephen Boag Dr Karim Bennaceur Professor Gavin Richardson et al.	Role of CMV-serostatus and CX3CR1 on lymphocyte kinetics and left ventricular remodelling in patients with acute myocardial infarction	2020
Rebecca Maier Dr Bilal Bawamia Dr Karim Bennaceur Sarah Dunn Dr Leanne Marsay et al.	Telomerase activation to reverse immunosenescence in elderly patients with acute coronary syndrome: Protocol for a randomized pilot trial	2020
Professor Gavin Richardson Dr Karim Bennaceur Emily Dookun Lilia Draganova Dr Gabriele Saretzki et al.	Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells	2018
Dr Catherine Drummond Arman Esfandiari Dr Xiaohong Lu Dr Claire Hutton Dr Jennifer Jackson et al.	TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation	2016
Rachael Horbury Dr Karim Bennaceur Catriona Barker Professor David Kavanagh Professor Tim Goodship et al.	Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)	2015
Dr Evgeniya Shmeleva Dr Stephen Boag Santosh Murali Dr Karim Bennaceur Dr Rajiv Das et al.	Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion	2015
Dr Stephen Boag Dr Rajiv Das Dr Evgeniya Shmeleva Dr Alan Bagnall Dr Mohaned Egred et al.	T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients	2015
Dr Karim Bennaceur Mark Atwill Nayef Al Zhrany Jedrzej Hoffmann Professor Bernard Keavney et al.	Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism	2014
Dr Evgeniya Shmeleva Dr Stephen Boag Santosh Murali Dr Karim Bennaceur Dr Stephen Todryk et al.	Effect of CMV-seropositivity on acute outcome of acute myocardial infarction	2014
Professor David Kavanagh Dr Isabel Pappworth Christine Hayes Dr Iain Moore Dr Eva-Maria Hunze et al.	Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon?	2012
Dr Karim Bennaceur Dr Eva-Maria Hunze James Staniforth Dr Lisa Turnbull Dr Valerie Wilson et al.	MCP (CD46) autoantibodies are associated with atypical hemolytic uremic syndrome	2012
Dr Ian Hardcastle Alex Liu Dr Eric Valeur Anna Watson Shafiq Ahmed et al.	Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein-Protein Interaction: Structure-Activity Studies Leading to Improved Potency	2011
Dr Karim Bennaceur Dr Catherine Drummond Professor Jane Endicott Emeritus Professor Bernard Golding Professor Roger Griffin et al.	MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones	2011
Dr Karim Bennaceur	Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells	2009
Dr Karim Bennaceur	Immunosuppressive networks in the tumour environment and their effect in dendritic cells	2009
Dr Karim Bennaceur	Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis	2006
Dr Karim Bennaceur	Studies of compounds that enhance sphingolipid metabolism in human keratinocytes	2006